Cediranib (AZD2171)

cediranib · AstraZeneca

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Cediranib (AZD2171), covering 2012-06-05 to 2021-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma [Phase 2]